Search

Alan L Rotman

Examiner (ID: 15220)

Most Active Art Unit
1201
Art Unit(s)
1802, 1612, 1201, 1203, 2899, 1625
Total Applications
2275
Issued Applications
1794
Pending Applications
68
Abandoned Applications
413

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16960843 [patent_doc_number] => 20210212342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => USE OF HUMAN MILK OLIGOSACCHARIDES IN CALVES FATTENING [patent_app_type] => utility [patent_app_number] => 17/130195 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2929 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17130195 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/130195
USE OF HUMAN MILK OLIGOSACCHARIDES IN CALVES FATTENING Dec 21, 2020 Pending
Array ( [id] => 18518578 [patent_doc_number] => 11708461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Method for preparing acylated crosslinked glycosaminoglycans [patent_app_type] => utility [patent_app_number] => 17/129366 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13064 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129366 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/129366
Method for preparing acylated crosslinked glycosaminoglycans Dec 20, 2020 Issued
Array ( [id] => 16776523 [patent_doc_number] => 20210113600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => RESTORING PHYSIOLOGY WITH SMALL MOLECULE MIMICS OF MISSING PROTEINS [patent_app_type] => utility [patent_app_number] => 17/127107 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11856 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127107 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/127107
RESTORING PHYSIOLOGY WITH SMALL MOLECULE MIMICS OF MISSING PROTEINS Dec 17, 2020 Pending
Array ( [id] => 18701293 [patent_doc_number] => 11787792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof [patent_app_type] => utility [patent_app_number] => 17/124606 [patent_app_country] => US [patent_app_date] => 2020-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16454 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17124606 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/124606
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof Dec 16, 2020 Issued
Array ( [id] => 19105835 [patent_doc_number] => 11958916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-16 [patent_title] => Use of poly alpha-1,3-glucan ethers as viscosity modifiers [patent_app_type] => utility [patent_app_number] => 17/118754 [patent_app_country] => US [patent_app_date] => 2020-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35969 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118754 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/118754
Use of poly alpha-1,3-glucan ethers as viscosity modifiers Dec 10, 2020 Issued
Array ( [id] => 18492256 [patent_doc_number] => 11697667 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-11 [patent_title] => Salts and polymorphs of cethromycin for the treatment of disease [patent_app_type] => utility [patent_app_number] => 17/109970 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 23475 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109970 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/109970
Salts and polymorphs of cethromycin for the treatment of disease Dec 1, 2020 Issued
Array ( [id] => 16868463 [patent_doc_number] => 20210161930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => USE OF SGLT-2 INHIBITORS IN THE DRYING-OFF OF NON-HUMAN MAMMALS [patent_app_type] => utility [patent_app_number] => 17/104414 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11877 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104414 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/104414
Use of SGLT-2 inhibitors in the drying-off of non-human mammals Nov 24, 2020 Issued
Array ( [id] => 16688412 [patent_doc_number] => 20210070888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => MODIFIED BIOPOLYMERS AND METHODS OF PRODUCING AND USING THE SAM [patent_app_type] => utility [patent_app_number] => 17/100523 [patent_app_country] => US [patent_app_date] => 2020-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100523 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/100523
MODIFIED BIOPOLYMERS AND METHODS OF PRODUCING AND USING THE SAM Nov 19, 2020 Abandoned
Array ( [id] => 16686750 [patent_doc_number] => 20210069225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => LIPONUCLEOTIDE-BASED THERAPY FOR ARDS [patent_app_type] => utility [patent_app_number] => 16/952557 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6927 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952557 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/952557
LIPONUCLEOTIDE-BASED THERAPY FOR ARDS Nov 18, 2020 Abandoned
Array ( [id] => 18460352 [patent_doc_number] => 11684630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-27 [patent_title] => Synthetic composition and method for modulating brain function and behaviour [patent_app_type] => utility [patent_app_number] => 17/099306 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5685 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099306 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/099306
Synthetic composition and method for modulating brain function and behaviour Nov 15, 2020 Issued
Array ( [id] => 18117751 [patent_doc_number] => 11549133 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-10 [patent_title] => Preparation method of amylodextrin [patent_app_type] => utility [patent_app_number] => 17/094962 [patent_app_country] => US [patent_app_date] => 2020-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3331 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094962 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/094962
Preparation method of amylodextrin Nov 10, 2020 Issued
Array ( [id] => 16686747 [patent_doc_number] => 20210069222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS [patent_app_type] => utility [patent_app_number] => 17/094591 [patent_app_country] => US [patent_app_date] => 2020-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15203 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094591 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/094591
TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS Nov 9, 2020 Pending
Array ( [id] => 16990162 [patent_doc_number] => 20210228582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => COMBINATION THERAPIES FOR TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 17/061821 [patent_app_country] => US [patent_app_date] => 2020-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7522 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061821 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/061821
COMBINATION THERAPIES FOR TREATMENT OF CANCER Oct 1, 2020 Abandoned
Array ( [id] => 16596571 [patent_doc_number] => 20210023102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => COMPOSITIONS FOR USE IN IMPROVING STOOL CONSISTENCY OR FREQUENCY IN INFANTS OR YOUNG CHILDREN [patent_app_type] => utility [patent_app_number] => 17/034650 [patent_app_country] => US [patent_app_date] => 2020-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10204 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17034650 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/034650
COMPOSITIONS FOR USE IN IMPROVING STOOL CONSISTENCY OR FREQUENCY IN INFANTS OR YOUNG CHILDREN Sep 27, 2020 Pending
Array ( [id] => 16718623 [patent_doc_number] => 20210085770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLS [patent_app_type] => utility [patent_app_number] => 17/025947 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25471 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17025947 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/025947
Neoglycoconjugates as vaccines and therapeutic tools Sep 17, 2020 Issued
Array ( [id] => 16726580 [patent_doc_number] => 20210093727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/021909 [patent_app_country] => US [patent_app_date] => 2020-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26356 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021909 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/021909
Sulfoalkyl ether cyclodextrin compositions Sep 14, 2020 Issued
Array ( [id] => 16671405 [patent_doc_number] => 20210060168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => ASIALOGLYCOPROTEIN RECEPTOR MEDIATED DELIVERY OF THERAPEUTICALLY ACTIVE CONJUGATES [patent_app_type] => utility [patent_app_number] => 17/011880 [patent_app_country] => US [patent_app_date] => 2020-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36594 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011880 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/011880
ASIALOGLYCOPROTEIN RECEPTOR MEDIATED DELIVERY OF THERAPEUTICALLY ACTIVE CONJUGATES Sep 2, 2020 Pending
Array ( [id] => 19290410 [patent_doc_number] => 12029749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-09 [patent_title] => Methods of treatment and maintenance therapy for bladder cancer using gemcitabine [patent_app_type] => utility [patent_app_number] => 17/010648 [patent_app_country] => US [patent_app_date] => 2020-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26169 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010648 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/010648
Methods of treatment and maintenance therapy for bladder cancer using gemcitabine Sep 1, 2020 Issued
Array ( [id] => 18051605 [patent_doc_number] => 11524976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-13 [patent_title] => Oligonucleotide synthesizer [patent_app_type] => utility [patent_app_number] => 17/005854 [patent_app_country] => US [patent_app_date] => 2020-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7274 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005854 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/005854
Oligonucleotide synthesizer Aug 27, 2020 Issued
Array ( [id] => 16898105 [patent_doc_number] => 20210177021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => METHOD OF PRODUCTION [patent_app_type] => utility [patent_app_number] => 16/999483 [patent_app_country] => US [patent_app_date] => 2020-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16999483 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/999483
METHOD OF PRODUCTION Aug 20, 2020 Pending
Menu